Sequent Scientific Limited (NSE:SEQUENT)

Market Cap	42.07B
Revenue (ttm)	15.51B
Net Income (ttm)	218.78M
Shares Out	n/a
EPS (ttm)	0.85
PE Ratio	192.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	208,300
Average Volume	437,226
Open	171.00
Previous Close	171.97
Day's Range	167.13 - 172.62
52-Week Range	117.35 - 240.70
Beta	1.09
RSI	33.10
Earnings Date	May 21, 2025

About Paycor HCM

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of antihelmentic, anti-parasites, antiprotozoal, NSAID, anti-bacterial, phosphorus supplement, beta agonist, analgesic, antimetic, anti- allergic, and congestive heart failure. It also offers analytical services; and finished dosage formulations, and VET formulation. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,244
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SEQUENT